Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy

C Ellen Lee, Andrea Kilgour, Y K James Lau, C Ellen Lee, Andrea Kilgour, Y K James Lau

Abstract

Background: Prostate cancer is the most commonly diagnosed non-melanoma cancer among men. Androgen deprivation therapy (ADT) has been the core therapy for men with advanced prostate cancer. It is only in recent years that clinicians began to recognize the cognitive-psychosocial side effects from ADT, which significantly compromise the quality of life of prostate cancer survivors. The objectives of the study are to determine the efficacy of a simple and accessible home-based, walking exercise program in promoting cognitive and psychosocial functions of men with prostate cancer receiving ADT.

Methods: A 6-month prospective, single-blinded, randomized controlled trial will be conducted to compare the Exercise Group with the Control Group. Twenty men with prostate cancer starting ADT will be recruited and randomly assigned to one of the two groups: the Exercise Group will receive instructions in setting up an individualized 6-month home-based, walking exercise program, while the Control Group will receive standard medical advice from the attending physician. The primary outcomes will be psychosocial and cognitive functions. Cognitive functions including memory, attention, working memory, and executive function will be assessed using a battery of neurocognitive tests at baseline and 6 months. Psychosocial functions including depression, anxiety and self-esteem will be assessed at baseline, 3 and 6 months using the Center for Epidemiological Studies Depression Scale, Spielberger State-Trait Anxiety Inventory, and Rosenberg Self-Esteem Scale.

Discussion: The significance of the cognitive-psychosocial side effects of ADT in men with prostate cancer has only been recently recognized, and the management remains unclear. This study addresses this issue by designing a simple and accessible home-based, exercise program that may potentially have significant impact on reducing the cognitive and psychosocial side effects of ADT, and ultimately improving the health-related quality of life in men with prostate cancer receiving ADT.

Trial registration: NCT00856102.

References

    1. Canadian Cancer Society. Prostate Cancer Statistics. In., May 19, 2010 edn. 2010.
    1. Stat Fact Sheets. Prostate Cancer. .
    1. Barry MJ, Delorenzo MA, Walker-Corkery ES, Lucas FL, Wennberg DC. The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study. BJU Int. 2006;98(5):973–978. doi: 10.1111/j.1464-410X.2006.06416.x.
    1. Abraham J, Allegra C, Gulley J. Bethesda Handbook of Clinical Oncology. 2. Baltimore, MD: Lippincott Williams & Wilkins; 2005.
    1. Cherrier MM, Rose AL, Higano C. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. J Urol. 2003;170(5):1808–1811. doi: 10.1097/01.ju.0000091640.59812.83.
    1. Green HJ, Pakenham KI, Headley BC, Yaxley J, Nicol DL, Mactaggart PN, Swanson C, Watson RB, Gardiner RA. Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. BJU Int. 2002;90(4):427–432. doi: 10.1046/j.1464-410X.2002.02917.x.
    1. Green HJ, Pakenham KI, Headley BC, Yaxley J, Nicol DL, Mactaggart PN, Swanson CE, Watson RB, Gardiner RA. Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial. BJU Int. 2004;93(7):975–979. doi: 10.1111/j.1464-410X.2004.04763.x.
    1. Jenkins VA, Bloomfield DJ, Shilling VM, Edginton TL. Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study. BJU Int. 2005;96(1):48–53. doi: 10.1111/j.1464-410X.2005.05565.x.
    1. Salminen E, Portin R, Korpela J, Backman H, Parvinen LM, Helenius H, Nurmi M. Androgen deprivation and cognition in prostate cancer. Br J Cancer. 2003;89(6):971–976. doi: 10.1038/sj.bjc.6601235.
    1. Salminen EK, Portin RI, Koskinen A, Helenius H, Nurmi M. Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin Cancer Res. 2004;10(22):7575–7582. doi: 10.1158/1078-0432.CCR-04-0750.
    1. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of the “androgen deprivation syndrome” in men receiving androgen deprivation for prostate cancer. Arch Intern Med. 2006;166(4):465–471.
    1. Almeida OP, Waterreus A, Spry N, Flicker L, Martins RN. One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology. 2004;29(8):1071–1081. doi: 10.1016/j.psyneuen.2003.11.002.
    1. Lawlor DA, Hopker SW. The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials. BMJ. 2001;322(7289):763–767. doi: 10.1136/bmj.322.7289.763.
    1. Broocks A, Bandelow B, Pekrun G, George A, Meyer T, Bartmann U, Hillmer-Vogel U, Ruther E. Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry. 1998;155(5):603–609.
    1. Sui X, Laditka JN, Church TS, Hardin JW, Chase N, Davis K, Blair SN. Prospective study of cardiorespiratory fitness and depressive symptoms in women and men. J Psychiatr Res. 2009;43(5):546–552. doi: 10.1016/j.jpsychires.2008.08.002.
    1. Tseng CN, Gau BS, Lou MF. The effectiveness of exercise on improving cognitive function in older people: a systematic review. J Nurs Res. 2011;19(2):119–131. doi: 10.1097/JNR.0b013e3182198837.
    1. Lautenschlager NT, Cox KL, Flicker L, Foster JK, van Bockxmeer FM, Xiao J, Greenop KR, Almeida OP. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA. 2008;300(9):1027–1037. doi: 10.1001/jama.300.9.1027.
    1. Liu-Ambrose T, Nagamatsu LS, Graf P, Beattie BL, Ashe MC, Handy TC. Resistance training and executive functions: a 12-month randomized controlled trial. Arch Intern Med. 2010;170(2):170–178. doi: 10.1001/archinternmed.2009.494.
    1. Angevaren M, Aufdemkampe G, Verhaar HJ, Aleman A, Vanhees L. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev. 2008;3:CD005381.
    1. Etnier JL, Nowell PM, Landers DM, Sibley BA. A meta-regression to examine the relationship between aerobic fitness and cognitive performance. Brain Res Rev. 2006;52(1):119–130. doi: 10.1016/j.brainresrev.2006.01.002.
    1. Barnes DE, Yaffe K, Satariano WA, Tager IB. A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults. J Am Geriatr Soc. 2003;51(4):459–465. doi: 10.1046/j.1532-5415.2003.51153.x.
    1. Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci. 2003;14(2):125–130. doi: 10.1111/1467-9280.t01-1-01430.
    1. Kramer AF, Colcombe SJ, McAuley E, Eriksen KI, Scalf P, Jerome GJ, Marquez DX, Elavsky S, Webb AG. Enhancing brain and cognitive function of older adults through fitness training. J Mol Neurosci. 2003;20(3):213–221. doi: 10.1385/JMN:20:3:213.
    1. Erickson KI, Prakash RS, Voss MW, Chaddock L, Hu L, Morris KS, White SM, Wojcicki TR, McAuley E, Kramer AF. Aerobic fitness is associated with hippocampal volume in elderly humans. Hippocampus. 2009;19(10):1030–1039. doi: 10.1002/hipo.20547.
    1. Pajonk FG, Wobrock T, Gruber O, Scherk H, Berner D, Kaizl I, Kierer A, Muller S, Oest M, Meyer T. et al.Hippocampal plasticity in response to exercise in schizophrenia. Arch Gen Psychiatry. 2010;67(2):133–143. doi: 10.1001/archgenpsychiatry.2009.193.
    1. Meeusen R, De Meirleir K. Exercise and brain neurotransmission. Sports Med. 1995;20(3):160–188. doi: 10.2165/00007256-199520030-00004.
    1. Yaffe K, Barnes D, Nevitt M, Lui LY, Covinsky K. A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch Intern Med. 2001;161(14):1703–1708. doi: 10.1001/archinte.161.14.1703.
    1. Weuve J, Kang JH, Manson JE, Breteler MM, Ware JH, Grodstein F. Physical activity, including walking, and cognitive function in older women. JAMA. 2004;292(12):1454–1461. doi: 10.1001/jama.292.12.1454.
    1. McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ. 2006;175(1):34–41. doi: 10.1503/cmaj.051073.
    1. Galantino M, Cannon N, Hoelker T, Iannaco J, Quinn L. Potential benefits of walking and yoga on perceived levels of cognitive decline and persistent fatigue in women with breast cancer. Rehab Oncol. 2007;25(3):3–16.
    1. Kirshbaum MN. A review of the benefits of whole body exercise during and after treatment for breast cancer. J Clin Nurs. 2007;16(1):104–121. doi: 10.1111/j.1365-2702.2006.01638.x.
    1. Blanchard CM, Courneya KS, Laing D. Effects of acute exercise on state anxiety in breast cancer survivors. Oncol Nurs Forum. 2001;28(10):1617–1621.
    1. Segar ML, Katch VL, Roth RS, Garcia AW, Portner TI, Glickman SG, Haslanger S, Wilkins EG. The effect of aerobic exercise on self-esteem and depressive and anxiety symptoms among breast cancer survivors. Oncol Nurs Forum. 1998;25(1):107–113.
    1. Pinto B, Maruyama N, Engerbretson T, Thebarge R. Participation in exercise, mood, and coping in survivors of early stage breast cancer. J Psychosoc Oncol. 1998;16:45–58.
    1. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA. 2005;293(20):2479–2486. doi: 10.1001/jama.293.20.2479.
    1. Irwin ML, McTiernan A, Manson JE, Thomson CA, Sternfeld B, Stefanick ML, Wactawski-Wende J, Craft L, Lane D, Martin LW. et al.Physical activity and survival in postmenopausal women with breast cancer: results from the women’s health initiative. Cancer Prev Res (Phila) 2011;4(4):522–529. doi: 10.1158/1940-6207.CAPR-10-0295.
    1. Keogh JW, Macleod RD. Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: a systematic review. J Pain Symptom Manage. 2011;43(1):96–110.
    1. Schulz KF, Grimes DA. Unequal group sizes in randomised trials: guarding against guessing. Lancet. 2002;359(9310):966–970. doi: 10.1016/S0140-6736(02)08029-7.
    1. Horvath S, Taylor DG, Marsh JP, Kriellaars DJ. The effect of pedometer position and normal gait asymmetry on step count accuracy. Appl Physiol Nutr Metab. 2007;32(3):409–415. doi: 10.1139/H07-001.
    1. Thomas S, Reading J, Shephard RJ. Revision of the Physical Activity Readiness Questionnaire (PAR-Q) Can J Sport Sci. 1992;17(4):338–345.
    1. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–381.
    1. Eston RG, Williams JG. Reliability of ratings of perceived effort regulation of exercise intensity. Br J Sports Med. 1988;22(4):153–155. doi: 10.1136/bjsm.22.4.153.
    1. Ceci R, Hassmen P. Self-monitored exercise at three different RPE intensities in treadmill vs field running. Med Sci Sports Exerc. 1991;23(6):732–738.
    1. Benedict RHB. Brief Visuospatial Memory Test-Revised: Professional Manual. Lutz, FL: Psychological Assessment Resources; 1997.
    1. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test Second Edition – Adult Version: Manual. San Antonio, TX: The Psychological Corporation; 2000.
    1. The Psychological Corporation. WAIS-III WMS-III Technical manual. San Antonio, TX: The Psychological Corporation Harcourt Brace & Company; 1997.
    1. Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford University Press; 1991.
    1. Lezak M, editor. Neuropsychological assessment. 3. New York, NY: Oxford University Press; 1995.
    1. Green P. Word Memory Test for Windows: User’s Manual and Program. Edmonton, Canada: Green’s Publishing; 2005.
    1. Crawford JR, Smith G, Maylor EA, Della Sala S, Logie RH. The Prospective and Retrospective Memory Questionnaire (PRMQ): Normative data and latent structure in a large non-clinical sample. Memory. 2003;11(3):261–275. doi: 10.1080/09658210244000027.
    1. Smith G, Della Sala S, Logie RH, Maylor EA. Prospective and retrospective memory in normal ageing and dementia: a questionnaire study. Memory. 2000;8(5):311–321. doi: 10.1080/09658210050117735.
    1. Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D) J Psychosom Res. 1999;46(5):437–443. doi: 10.1016/S0022-3999(99)00004-5.
    1. Spielberger C, Gorsuch R, Lushene R, Vagg P, Jacobs G. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
    1. Lewis F, Bloom J. Psychosocial adjustment to breast cancer: A review of selected literature. Int J Psychiatry Med. 1987;9:1–17.
    1. Zenmore R, Shepel L. Effects of breast cancer and mastectomy on emotional support and adjustment. Soc Sci Med. 1989;28:19–27. doi: 10.1016/0277-9536(89)90302-X.
    1. Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology. 1997;50(6):920–928. doi: 10.1016/S0090-4295(97)00459-7.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa